Apixaban Tied to Lower Risk for Recurrent VTE in Dialysis Population
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Diagnosis & Disease Information
Mineralocorticoid Receptor Antagonists May Lower Death Risk in Dialysis
Investigators reviewed 13 trials of spironolactone and 1 trial of eplerenone.
SARS-CoV-2 Antibody Response Durable for at Least 6 Months in Dialysis
Older adults and individuals with diabetes did not experience a faster decline in SARS-CoV-2 antibody titers, investigators found.
Psoriasis Treatment May Decrease Infection, Death Risk in End-Stage Kidney Disease
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
